22.05.2022 Views

DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Goldwater LJ. Mercury; a History of Quicksilver. Baltimore,

York Press, 1972.

Gordis L. Epidemiology, 4th ed. Philadelphia, Saunders Elsevier,

2008.

Grandjean P, Budtz-Jorgensen E, White RF, et al. Methylmercury

exposure biomarkers as indicators of neurotoxicity in children

aged 7 years. Am J Epidemiol, 1999, 150:301–305.

Groopman JD, Johnson D, Kensler TW. Aflatoxin and hepatitis

B virus biomarkers: A paradigm for complex environmental

exposures and cancer risk. Cancer Biomark, 2005, 1:5–14.

Groopman JD, Kensler TW, Wild CP. Protective interventions to

prevent aflatoxin-induced carcinogenesis in developing countries.

Annu Rev Public Health, 2008, 29:187–203.

Grosse SD, Matte TD, Schwartz J, Jackson RJ. Economic gains

resulting from the reduction in children’s exposure to lead in the

United States. Environ Health Perspect, 2002, 110:563–569.

Guengerich FP, Johnson WW, Ueng YF, et al. Involvement of

cytochrome P450, glutathione S-transferase, and epoxide

hydrolase in the metabolism of aflatoxin B1 and relevance to

risk of human liver cancer. Environ Health Perspect, 1996,

104(suppl):557–562.

Hall AH. Chronic arsenic poisoning. Toxicol Lett, 2002, 128:69–72.

Hartwig A, Asmuss M, Ehleben I, et al. Interference by toxic

metal ions with DNA repair processes and cell cycle control:

Molecular mechanisms. Environ Health Perspect, 2002,

110(suppl):797–799.

Heron J, Golding J. Thimerosal exposure in infants and developmental

disorders: A prospective cohort study in the United

Kingdom does not support a causal association. Pediatrics,

2004, 114:577–583.

Hussain SP, Schwank J, Staib F, et al. TP53 mutations and hepatocellular

carcinoma: Insights into the etiology and pathogenesis

of liver cancer. Oncogene, 2007, 26:2166–2176.

Ibrahim D, Froberg B, Wolf A, Rusyniak DE. Heavy metal poisoning:

Clinical presentations and pathophysiology. Clin Lab

Med, 2006, 26:67–97.

International Agency for Research on Cancer (IARC). Beryllium,

cadmium, mercury, and exposures in the glass manufacturing

industry. In: Monographs on the Evaluation of Carcinogenic

Risks to Humans, Vol. 58. Lyon, France, IARC Press, 1993.

International Agency for Research on Cancer (IARC).

Chromium, nickel, and welding. In: Monographs on the

Evaluation of Carcinogenic Risks to Humans, Vol. 49. Lyon,

France, IARC Press, 1990.

International Agency for Research on Cancer (IARC). Inorganic

lead and organic lead compounds. In: Monographs on the

Evaluation of Carcinogenic Risks to Humans, Vol. 87. Lyon,

France, IARC Press, 2006.

International Agency for Research on Cancer (IARC). Some traditional

herbal medicines, some mycotoxins, naphthalene, and

styrene. In: Monographs on the Evaluation of Carcinogenic

Risks to Humans, Vol. 82. Lyon, France, IARC Press, 2002.

Jarup L, Akesson A. Current status of cadmium as an environmental

health problem. Toxicol Appl Pharmacol, 2009,

238:201–208.

Kalia K, Flora SJ. Strategies for safe and effective therapeutic

measures for chronic arsenic and lead poisoning. J Occup

Health, 2005, 47:1–21.

Kensler TW, Egner PA, Wang JB, et al. Chemoprevention of hepatocellular

carcinoma in aflatoxin endemic areas. Gastroenterology,

2004, 127:S310–S318.

Klaunig JE, Kamendulis LM. Chemical carcinogens. In:

Klaassen CD, ed. Casarett & Doull’s Toxicology: The Basic

Science of Poisons. New York, McGraw-Hill, 2008.

Lanphear BP, Hornung R, Khoury J, et al. Low-level environmental

lead exposure and children’s intellectual function: An

international pooled analysis. Environ Health Perspect, 2005,

113:894–899.

Levin R, Brown MJ, Kashtock ME, et al. Lead exposures in U.S.

children, 2008: Implications for prevention. Environ Health

Perspect, 2008, 116:1285–1293.

Liu J, Goyer RA, Waalkes MP. Toxic effects of metals. In:

Klaassen CD, ed. Casarett & Doull’s Toxicology: The Basic

Science of Poisons. New York, McGraw-Hill, 2008.

Mead MN. Arsenic: In search of an antidote to a global poison.

Environ Health Perspect, 2005, 113:A378–A386.

Mena S, Ortega A, Estrela JM. Oxidative stress in environmentalinduced

carcinogenesis. Mutat Res, 2009, 674:36–44.

Myers GJ, Davidson PW, Cox C, et al. Prenatal methylmercury

exposure from ocean fish consumption in the Seychelles child

development study. Lancet, 2003, 361:1686–1692.

Myers GJ, Davidson PW, Strain JJ. Nutrient and methyl mercury

exposure from consuming fish. J Nutr, 2007, 137:2805–2808.

National Toxicology Program (NTP). Cadmium and cadmium

compounds. In: Report on Carcinogens. Research Triangle

Park, NC, NTP, 2004, pp. III42–III44.

Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. Lead

exposure and cardiovascular disease—A systematic review.

Environ Health Perspect, 2007, 115:472–482.

Needleman HL, Riess JA, Tobin MJ, et al. Bone lead levels and

delinquent behavior. JAMA, 1996, 275:363–369.

Omenn GS, Goodman G, Thornquist M, et al. Chemoprevention

of lung cancer: The beta-Carotene and Retinol Efficacy Trial

(CARET) in high-risk smokers and asbestos-exposed workers.

IARC Sci Publ, 1996, 136:67–85.

Penning TM. Polycyclic aromatic hydrocarbons: Multiple metabolic

pathways and DNA lesions formed. In: Geactinov NE,

Broyde S, eds. The Chemical Biology of DNA Damage. New

York, Wiley-VCH, 2009.

Rogan WJ, Dietrich KN, Ware JH, et al. The effect of chelation

therapy with succimer on neuropsychological development

in children exposed to lead. N Engl J Med, 2001, 344:

1421–1426.

Salnikow K, Zhitkovich A. Genetic and epigenetic mechanisms

in metal carcinogenesis and cocarcinogenesis: Nickel, arsenic,

and chromium. Chem Res Toxicol, 2008, 21:28–44.

Sánchez-Fructuoso AI, Cano M, Arroyo M, et al. Lead mobilization

during calcium disodium ethylenediaminetetraacetate

chelation therapy in treatment of chronic lead poisoning. Am

J Kidney Dis, 2002, 40:51–58.

Schober SE, Mirel LB, Graubard BI, et al. Blood lead levels and

death from all causes, cardiovascular disease, and cancer:

Results from the NHANES III mortality study. Environ Health

Perspect, 2006, 114:1538–1541.

Silbergeld EK. Facilitative mechanisms of lead as a carcinogen.

Mutat Res, 2003, 533:121–133.

Smith AH, Marshall G, Yuan Y, et al. Increased mortality from

lung cancer and bronchiectasis in young adults after exposure

to arsenic in utero and in early childhood. Environ Health

Perspect, 2006, 114:1293–1296.

Sylla A, Diallo MS, Castegnaro J, Wild CP. Interactions between

hepatitis B virus infection and exposure to aflatoxins in the

1877

CHAPTER 67

ENVIRONMENTAL TOXICOLOGY: CARCINOGENS AND HEAVY METALS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!